Advertisement

Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma

Published:January 06, 2022DOI:https://doi.org/10.1016/j.clgc.2022.01.001

      Highlights

      • Palliative interventions for Stage IV renal cell carcinoma (RCC) are poorly understood.
      • Palliative intervention use has minimally increased for metastatic RCC.
      • Several factors affect palliative intervention use for metastatic RCC.
      • Treatment-specific factors influence palliative intervention use for metastatic RCC

      Abstract

      Introduction

      Several guidelines have adopted early integration of palliative intervention (PI) into oncologic care to improve quality of life among patients with advanced malignancies. However, PI utilization patterns and factors associated with its use in metastatic renal cell carcinoma are poorly understood.

      Patients and Methods

      Using the National Cancer Database (NCDB), we abstracted patients diagnosed with Stage IV RCC from 2004 to 2014 and evaluated the utilization of PI within this cohort. Socioeconomic and clinical factors were compared for patients receiving and not receiving PI for metastatic RCC. Multivariable logistic regression (MLR) models identified factors that were associated with receipt of PI within overall cohort and treatment-based cohorts.

      Results

      We identified 42,014 patients with Stage IV RCC, of which 7,912 patients received PI. From 2004 to 2014, the use of PI minimally increased from 17% to 20% for Stage IV RCC. MLR analysis demonstrated that increased comorbidities, insurance status, higher education status, facility location, care at a comprehensive cancer program or integrated network, sarcomatoid histology, and treatment type significantly increased the likelihood of PI use. Various socioeconomic, clinical, and geographical factors that are associated with use of PI-based on the treatment received for Stage IV RCC.

      Conclusions

      While PI utilization has minimally increased for Stage IV RCC, there are several geographic, socioeconomic, and clinical factors that predict its use among patients with Stage IV RCC in a treatment-specific manner. Taken together, this suggests the need for earlier initiation of PI in a more equitable and systematic fashion among patients with metastatic RCC.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Genitourinary Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hugar LA
        • Wulff-Burchfield EM
        • Winzelberg GS
        • Jacobs BL
        • Davies BJ.
        Incorporating palliative care principles to improve patient care and quality of life in urologic oncology.
        Nat Rev Urol. 2021; https://doi.org/10.1038/s41585-021-00491-z
        • Morrison RS
        • Dietrich J
        • Ladwig S
        • et al.
        Palliative care consultation teams cut hospital costs for Medicaid beneficiaries.
        Health Aff (Millwood). 2011; 30: 454-463https://doi.org/10.1377/hlthaff.2010.0929
        • Khandelwal N
        • Kross EK
        • Engelberg RA
        • Coe NB
        • Long AC
        • Curtis JR.
        Estimating the effect of palliative care interventions and advance care planning on ICU utilization: a systematic review.
        Crit Care Med. 2015; 43: 1102-1111https://doi.org/10.1097/CCM.0000000000000852
        • Temel JS
        • Greer JA
        • Muzikansky A
        • et al.
        Early palliative care for patients with metastatic non-small-cell lung cancer.
        N Engl J Med. 2010; 363: 733-742https://doi.org/10.1056/NEJMoa1000678
        • Association AU
        Clin Ethics Urol. 2021; 20112008
      1. Dunn GP, Martensen R, Weissman D. Surgical palliative care: a resident's guide. Chicago: American College of Surgeons; 2009:278.

        • Alliance WPC
        Global Atlas of Palliative Care.
        2nd ed. World Health Organization, London, UK2020
        • Zisman A
        • Pantuck AJ
        • Wieder J
        • et al.
        Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.
        J Clin Oncol. 2002; 20: 4559-4566https://doi.org/10.1200/JCO.2002.05.111
        • Nerich V
        • Hugues M
        • Paillard MJ
        • et al.
        Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma.
        Onco Targets Ther. 2014; 7: 365-374https://doi.org/10.2147/OTT.S56370
        • Higginson IJ
        • Evans CJ.
        What is the evidence that palliative care teams improve outcomes for cancer patients and their families?.
        Cancer J. 2010; 16: 423-435https://doi.org/10.1097/PPO.0b013e3181f684e5
        • Lec PM
        • Lenis AT
        • Brisbane W
        • et al.
        Trends in palliative care interventions among patients with advanced bladder, prostate, or kidney cancer: A retrospective cohort study.
        Urol Oncol. 2020; 38 (e851-854 e859): 854https://doi.org/10.1016/j.urolonc.2020.04.029
        • Abdollah F
        • Sammon JD
        • Majumder K
        • et al.
        Racial disparities in end-of-life care among patients with prostate cancer: A population-based study.
        J Natl Compr Canc Netw. 2015; 13: 1131-1138https://doi.org/10.6004/jnccn.2015.0138
        • Mazzone E
        • Knipper S
        • Mistretta FA
        • et al.
        Trends and social barriers for inpatient palliative care in patients with metastatic bladder cancer receiving critical care therapies.
        J Natl Compr Canc Netw. 2019; 17: 1344-1352https://doi.org/10.6004/jnccn.2019.7319
        • Hugar LA
        • Lopa SH
        • Yabes JG
        • et al.
        Palliative care use amongst patients with bladder cancer.
        BJU Int. 2019; 123: 968-975https://doi.org/10.1111/bju.14708
        • Huen K
        • Huang C
        • Liu H
        • et al.
        Outcomes of an integrated urology-palliative care clinic for patients with advanced urological cancers: maintenance of quality of life and satisfaction and high rate of hospice utilization through end of life.
        Am J Hosp Palliat Care. 2019; 36: 801-806https://doi.org/10.1177/1049909119833663
        • Mistry NA
        • Raza SJ
        • Siddiqui SA.
        Analysis of inpatient palliative care consultations for patients with metastatic prostate cancer.
        Am J Hosp Palliat Care. 2020; 37: 136-141https://doi.org/10.1177/1049909119864576
        • Bakitas M
        • Lyons KD
        • Hegel MT
        • et al.
        Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial.
        JAMA. 2009; 302 (302/7/741 [pii]): 741-749https://doi.org/10.1001/jama.2009.1198
        • Kumar P
        • Casarett D
        • Corcoran A
        • et al.
        Utilization of supportive and palliative care services among oncology outpatients at one academic cancer center: determinants of use and barriers to access.
        J Palliat Med. 2012; 15: 923-930https://doi.org/10.1089/jpm.2011.0217
        • Szekendi MK
        • Vaughn J
        • Lal A
        • Ouchi K
        • Williams MV.
        The prevalence of inpatients at 33 U.S. hospitals appropriate for and receiving referral to palliative care.
        J Palliat Med. 2016; 19: 360-372https://doi.org/10.1089/jpm.2015.0236
        • Wancata LM
        • Hinshaw DB
        • Suwanabol PA.
        Palliative care and surgical training: are we being trained to be unprepared?.
        Ann Surg. 2017; 265: 32-33https://doi.org/10.1097/SLA.0000000000001779
        • Suwanabol PA
        • Kanters AE
        • Reichstein AC
        • et al.
        Characterizing the Role of U.S. surgeons in the provision of palliative care: a systematic review and mixed-methods meta-synthesis.
        J Pain Symptom Manage. 2018; 55 (e1195): 1196-1215https://doi.org/10.1016/j.jpainsymman.2017.11.031
        • Spetz J
        • Dudley N
        • Trupin L
        • Rogers M
        • Meier DE
        • Dumanovsky T.
        Few hospital palliative care programs meet national staffing recommendations.
        Health Aff (Millwood). 2016; 35: 1690-1697https://doi.org/10.1377/hlthaff.2016.0113
        • Harrison KL
        • Dzeng E
        • Ritchie CS
        • et al.
        Addressing palliative care clinician burnout in organizations: a workforce necessity, an ethical imperative.
        J Pain Symptom Manage. 2017; 53: 1091-1096https://doi.org/10.1016/j.jpainsymman.2017.01.007
        • Roeland EJ
        • Triplett DP
        • Matsuno RK
        • et al.
        Patterns of palliative care consultation among elderly patients with cancer.
        J Natl Compr Canc Netw. 2016; 14: 439-445https://doi.org/10.6004/jnccn.2016.0050
        • Ornstein KA
        • Roth DL
        • Huang J
        • et al.
        Evaluation of racial disparities in hospice use and end-of-life treatment intensity in the REGARDS cohort.
        JAMA Netw Open. 2020; 3e2014639https://doi.org/10.1001/jamanetworkopen.2020.14639
        • Rhodes RL
        • Batchelor K
        • Lee SC
        • Halm EA.
        Barriers to end-of-life care for African Americans from the providers' perspective: opportunity for intervention development.
        Am J Hosp Palliat Care. 2015; 32: 137-143https://doi.org/10.1177/1049909113507127
        • Rabow MW
        • Benner C
        • Shepard N
        • Meng MV.
        Concurrent urologic and palliative care after cystectomy for treatment of muscle-invasive bladder cancer.
        Urol Oncol. 2015; 33 (e223): 267-269https://doi.org/10.1016/j.urolonc.2015.02.012
        • Sinclair CT
        • Kalender-Rich JL
        • Griebling TL
        • Porter-Williamson K.
        Palliative care of urologic patients at end of life.
        Clin Geriatr Med. 2015; 31: 667-678https://doi.org/10.1016/j.cger.2015.07.002
        • Demme RA
        • Singer EA
        • Greenlaw J
        • Quill TE.
        Ethical issues in palliative care.
        Anesthesiol Clin. 2006; 24 (S0889-8537(05)00110-0 [pii]): 129-144https://doi.org/10.1016/j.atc.2005.11.004
        • von Gunten CF.
        Secondary and tertiary palliative care in US hospitals.
        JAMA. 2002; 287: 875-881https://doi.org/10.1001/jama.287.7.875